Lupus & antiphospholipid syndrome

Anti–Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody–Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository

Arthritis RheumatolPublished Cross-sectional study

Authors' conclusion

These data reveal high levels of anti-NET antibodies in 45% of aPL-positive patients, where they potentially activate the complement cascade.

Study context

Population
Multinational cohort of antiphospholipid (aPL)-positive patients without lupus (APS ACTION Clinical Database and Repository)308 met APS classification criteria
Participants
389 participants
Outcome
Presence of elevated anti-NET IgG/IgM levels
Methodological detailsmultinational cohort, multivariate logistic regression with best variable model selection, autoantigen microarray (subset)
  • Multinational cohort
  • Multivariate logistic regression with best variable model selection
  • Autoantigen microarray (subset)

Main finding

As reported in the abstract

Elevated anti-NET IgG and/or IgM

Elevated anti-NET IgG and/or IgM in aPL-positive patients

45%

Observational data: associations, not effects.

Further findings

Associations of anti-NET antibodies

High anti-NET levels associated with more circulating MPO-DNA complexes (NET biomarker)
Positive anti-NET IgG associated with brain white matter lesions, even after adjusting for demographics and aPL profiles
Anti-NET IgM tracked with complement consumption after controlling for aPL profiles; high anti-NET IgM sera efficiently deposited C3d on NETs

Autoantibody profiles by autoantigen microarray (subset)

Anti-NET IgG positivity associated with autoantibodies to citrullinated histones, heparan sulfate proteoglycan, laminin, MPO-DNA complexes and nucleosomes
Anti-NET IgM positivity associated with autoantibodies to ssDNA, dsDNA and proliferating cell nuclear antigen
  • n = 214

Original publication

Anti–Neutrophil Extracellular Trap Antibodies in Antiphospholipid Antibody–Positive Patients: Results From the Antiphospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking Clinical Database and Repository. Arthritis Rheumatol. Published 18 May 2023. doi:10.1002/art.42489

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.